Connect your AI

Sutro Biopharma STRO Book value per share

Book value per share at other companies

PfizerPFE

$15.72-0.6%

Gilead SciencesGILD

$18.75+23.2%

RegenxbioRGNX

$0.40-92.5%

Nuvectis Pharma, Inc.NVCT

$0.61-42.2%

XencorXNCR

$6.85-21.1%

AnaptysBio, Inc.ANAB

$0.44-60.0%

Other financials

Income statement

Revenue$14.5M-16.5%

Operating income-$29.7M+56.7%

Net income-$38.5M+49.3%

EPS (diluted)-$2.94+67.6%

Balance sheet

Cash & equivalents$73.7M-30.6%

Total debt$13.6M-36.3%

Total equity-$66.9M-159%

Total assets$242.0M-24.7%

Cash flow

Operating cash flow-$42.3M+37.7%

CapEx--100%

Free cash flow-$42.3M+37.8%

Valuation

Market cap$489.66M+624%

Enterprise value$429.61M-2,600%

P/S4.9×+3.9×

Profitability

Operating margin-120%-48.6pp

Net margin-154.2%-56.7pp

FCF margin-152.2%-51.1pp

Returns & leverage

Return on equity-234.2%—

Debt / equity0.5×+0.3×

Current ratio3.1×+1.0×

Where this comes from

Calculated from Sutro Biopharma’s reported figures.

total stockholders equity/weighted shares diluted=-$5.11

Based on the most recent quarter.

The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sutro Biopharma's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Sutro Biopharma's book value per share?: Sutro Biopharma (STRO) reported book value per share of -$5.11 in Q1 2026.
How has Sutro Biopharma's book value per share changed year-over-year?: Sutro Biopharma's book value per share decreased by 65.7% year-over-year, from -$3.09 to -$5.11.
What is the long-term trend for Sutro Biopharma's book value per share?: Over 5 years (2020 to 2025), Sutro Biopharma's book value per share has grown at a 8.9% compound annual growth rate (CAGR), from $10.19 to -$15.59.
What does book value per share mean?: Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.